DR Congo launches clinical trial for new Ebola vaccine

The Democratic Republic of the Congo has launched a clinical trial for a new Ebola vaccine as part of efforts to limit the spread of the disease and bolster the health response.

The ongoing trials aim to assess the vaccine’s safety and effectiveness, identify target groups for vaccination, and monitor potential side effects throughout the various research phases.

Experts noted that the start of the trial does not mean the vaccine is approved for general use or that its final efficacy has been proven, as results will depend on data collected and analyzed during the clinical study.

Health authorities in the Democratic Republic of the Congo continue to monitor cases, isolate infected individuals, trace contacts, raise public awareness, and equip frontline workers.